rank	phenotype	cui	assoc in neigh	assoc in intom	probability	Benjamini-Hochberg	genes	
2	Gastrointestinal stromal tumor	C0238198	3	340	0.0	1.4388489208633095e-05	SLC16A7,SLC16A1,SLC16A3
13	Pleural Mesothelioma	C0812413	2	240	8.13540569466e-07	9.35251798561151e-05	SLC16A1,SLC16A3
15	Hypoglycemia, neonatal, simulating foetopathia diabetica	C0020615	2	265	1.09651981217e-06	0.00010791366906474819	SLC16A7,SLC16A1
20	Abnormality of endocrine pancreas physiology	C4023047	1	27	3.21086157307e-06	0.00014388489208633093	SLC16A1
21	Recurrent E. coli infections	C0014836	1	29	3.71375594466e-06	0.0001510791366906475	SLC16A1
22	Muscle stiffness	C0221170	1	30	3.97889124049e-06	0.000158273381294964	SLC16A1
23	Fuchs' Endothelial Dystrophy	C0016781	1	45	9.05184010136e-06	0.00016546762589928057	SLC16A1
24	Hippocampal sclerosis	C1504404	1	45	9.05184010136e-06	0.00017266187050359714	SLC16A1
25	Sickle Cell Trait	C0037054	1	47	9.88342564012e-06	0.00017985611510791367	SLC16A1
26	Malignant neoplasm of tongue	C0153349	1	50	1.11990510765e-05	0.0001870503597122302	SLC16A3
27	Tongue Carcinoma	C0558353	1	54	1.30809116071e-05	0.00019424460431654677	SLC16A3
28	Ketoacidosis	C0022638	1	57	1.45881116467e-05	0.0002014388489208633	SLC16A1
29	Small cell lung cancer	C0149925	2	638	1.54026998859e-05	0.00020863309352517988	SLC16A1,SLC16A3
30	Body Weight Changes	C0005911	1	59	1.5638427816e-05	0.00021582733812949639	SLC16A7
31	Right ventricular hypertrophy	C0162770	1	69	2.14366637983e-05	0.00022302158273381295	SLC16A1
32	Epilepsy, generalized, with febrile seizures plus, type 6 (2)	C0014548	1	70	2.206658422e-05	0.00023021582733812951	SLC16A1
33	Muscle cramps	C0026821	1	87	3.41674558568e-05	0.00023741007194244605	SLC16A1
34	Coma	C0009421	1	93	3.90659414722e-05	0.0002446043165467626	SLC16A1
35	Advanced cancer	C0877373	1	100	4.51941746642e-05	0.0002517985611510791	SLC16A1
36	Fibrinogen Adverse Event	C1561955	1	108	5.27429259283e-05	0.00025899280575539566	SLC16A7
37	Abnormality of pancreas physiology	C4023048	1	115	5.98245571884e-05	0.00026618705035971225	SLC16A1
38	Abnormal circulating insulin level	C4073161	1	123	6.84623048886e-05	0.0002733812949640288	SLC16A1
39	Abnormal insulin level	C4073160	1	123	6.84623048886e-05	0.00028057553956834533	SLC16A1
40	Arteriosclerosis	C0003850	2	1059	7.05724626775e-05	0.00028776978417266187	SLC16A1,SLC16A3
41	Colorectal Neoplasms	C0009404	2	1164	9.37383823285e-05	0.0002949640287769784	SLC16A7,SLC16A1
42	Neoplastic Cell Transformation	C0007621	1	144	9.38958231873e-05	0.000302158273381295	SLC16A1
43	Hearing Loss, Partial	C0018772	1	150	0.000101896036392	0.00030935251798561153	SLC16A1
44	Insulinoma	C0021670	1	157	0.000111641165192	0.000316546762589928	SLC16A1
45	Multiple Myeloma	C0026764	2	1236	0.000112248100861	0.0003237410071942446	SLC16A1,SLC16A3
46	Disseminated Malignant Neoplasm	C0346957	1	162	0.000118873327665	0.00033093525179856114	SLC16A3
47	Atherosclerosis	C0004153	2	1271	0.000122064522343	0.00033812949640287773	SLC16A1,SLC16A3
48	Abnormality of blood glucose concentration	C4023597	1	166	0.000124821733594	0.00034532374100719427	SLC16A1
49	Epilepsy, Temporal Lobe	C0014556	1	192	0.000167007953268	0.00035251798561151075	SLC16A1
50	Abnormality of circulating enzyme level	C4023591	1	194	0.000170505722228	0.00035971223021582735	SLC16A1
51	Elevated serum creatine phosphokinase	C0241005	1	195	0.000172268056388	0.0003669064748201439	SLC16A1
52	Abnormality of the pancreas	C4025751	1	212	0.000203607374713	0.0003741007194244604	SLC16A1
53	Reduced consciousness/confusion	C0234428	1	213	0.000205531887329	0.000381294964028777	SLC16A1
54	Primary pulmonary hypertension	C0152171	1	227	0.000233420385759	0.00038848920863309355	SLC16A1
55	Adenocarcinoma of colon	C0338106	1	240	0.000260894967957	0.0003956834532374101	SLC16A3
56	Glioblastoma	C0017636	2	1645	0.000264779080465	0.0004028776978417266	SLC16A1,SLC16A3
57	Autism spectrum disorders	C1510586	1	247	0.000276317887002	0.00041007194244604316	SLC16A7
58	Heterogeneous	C0019409	1	248	0.000278557086696	0.00041726618705035975	SLC16A1
59	Deafness, autosomal recessive 44	C0011053	1	257	0.000299113622355	0.0004244604316546763	SLC16A1
60	Abnormality of circulating hormone level	C4025652	1	262	0.000310847863441	0.00043165467625899277	SLC16A1
61	Abnormality of circulating protein level	C4023679	1	274	0.000339924727773	0.00043884892086330936	SLC16A1
62	Cardiomegaly	C0018800	1	279	0.000352420826996	0.0004460431654676259	SLC16A7
63	Abnormality of acid-base homeostasis	C0001118	1	286	0.00037029143065	0.0004532374100719425	SLC16A1
64	Acidosis	C0001122	1	289	0.000378084573817	0.00046043165467625903	SLC16A1
65	Squamous cell carcinoma	C0007137	2	1855	0.000379758464869	0.0004676258992805755	SLC16A1,SLC16A3
66	T-cell lymphoma	C0079772	1	302	0.00041278495607	0.0004748201438848921	SLC16A1
67	Male infertility	C0021364	1	303	0.000415516783842	0.00048201438848920864	SLC16A7
68	Pulmonary arterial hypertension	C3203102	1	314	0.000446156951787	0.0004892086330935252	SLC16A1
69	Recurrent tumor	C0521158	1	320	0.000463325172246	0.0004964028776978418	SLC16A3
70	Non-small cell lung carcinoma	C0007131	2	1993	0.000471027515459	0.0005035971223021583	SLC16A7,SLC16A1
71	Glioma	C0017638	2	1997	0.000473870708195	0.0005107913669064748	SLC16A1,SLC16A3
72	Pulmonary hypertension, neonatal, susceptibility to	C0020542	1	333	0.000501625105293	0.0005179856115107913	SLC16A3
